Tallahassee ‘Molly’ Drug Trafficker Sentenced to 22 Years in Federal Prison

Below is an official statement from the U.S. Attorney’s Office for the Northern District of Florida regarding a drug trafficker in Tallahassee:

Ennis Alexander Andrews, 44, of Tallahassee, Florida, was sentenced to 264 months in federal prison after previously pleading guilty to possession with intent to distribute alpha-Pyrrolidinopentiophenone, commonly known as “alpha-pyrrolidinovalerophenone,” “alpha-PVP,” or “Molly.”  United States Attorney Jason R. Coody, for the Northern District of Florida, announced the sentence.

“Our local, state, and federal law enforcement partners work tirelessly to keep us safe by removing addictive and deadly controlled substances from our communities,” said U.S. Attorney Coody. “We remain committed to support their efforts through the investigation and prosecution of criminals bringing drugs into North Florida. The imposed sentences illustrate the significant consequences of harming our citizens through their illicit drug trafficking activities.”

During August through October 2022, investigators conducted a series of controlled drug purchases of “Molly” from Andrews, after which warrants for his arrest were obtained.  When officers went to arrest Andrews on October 13, 2022, he attempted to flee.  After being detained, several ounces of “Molly” were found on his person.

“These dedicated efforts by investigators and the prosecution team highlight our shared commitment to addressing illegal drug activity in our community,” said Chief of Police Lawrence Revell of the Tallahassee Police Department. “We know violent crime is often linked to drug activity, and it significantly reduces the quality of life for citizens. We will do everything we can to protect and serve those who call Tallahassee home.”

At the time of the investigation, Andrews was serving a term of federal supervised release imposed after his release from prison in July 2022. Andrews prison sentence will be followed by 6 additional years of supervised release.